Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine
- PMID: 23607309
- DOI: 10.3109/07388551.2013.778228
Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine
Abstract
Exploiting the burgeoning fields of genomics, proteomics and metabolomics improves understanding of human physiology and, critically, the mutations that signal disease susceptibility. Through these emerging fields, rational design approaches to diagnosis, drug development and ultimately personalized medicine are possible. Personalized medicine and point-of-care testing techniques must fulfill a host of constraints for real-world applicability. Point-of-care devices (POCDs) must ultimately provide a cost-effective alternative to expensive and time-consuming laboratory tests in order to assist health care personnel with disease diagnosis and treatment decisions. Sensor technologies are also expanding beyond the more traditional classes of biomarkers--nucleic acids and proteins--to metabolites and direct detection of pathogens, ultimately increasing the palette of available techniques for the use of personalized medicine. The technologies needed to perform such diagnostics have also been rapidly evolving, with each generation being increasingly sensitive and selective while being more resource conscious. Ultimately, the final hurdle for all such technologies is to be able to drive consumer adoption and achieve a meaningful medical outcome for the patient.
Keywords: Biosensors; drugs; personalized medicine; point of care devices.
Similar articles
-
The future: biomarkers, biosensors, neuroinformatics, and e-neuropsychiatry.Int Rev Neurobiol. 2011;101:375-400. doi: 10.1016/B978-0-12-387718-5.00015-8. Int Rev Neurobiol. 2011. PMID: 22050860 Review.
-
Personalized oncology: recent advances and future challenges.Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Metabolism. 2013. PMID: 22999010 Review.
-
Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.Value Health. 2013 Sep-Oct;16(6 Suppl):S1-3. doi: 10.1016/j.jval.2013.06.004. Value Health. 2013. PMID: 24034305
-
Omics-based nanomedicine: the future of personalized oncology.Cancer Lett. 2014 Sep 28;352(1):126-36. doi: 10.1016/j.canlet.2013.07.029. Epub 2013 Aug 11. Cancer Lett. 2014. PMID: 23941830 Review.
-
Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.Complement Ther Med. 2012 Feb-Apr;20(1-2):93-9. doi: 10.1016/j.ctim.2011.10.007. Epub 2011 Nov 30. Complement Ther Med. 2012. PMID: 22305254
Cited by
-
Comparative Kinetic Analysis of Closed-Ended and Open-Ended Porous Sensors.Nanoscale Res Lett. 2016 Dec;11(1):395. doi: 10.1186/s11671-016-1614-3. Epub 2016 Sep 13. Nanoscale Res Lett. 2016. PMID: 27620193 Free PMC article.
-
Development of a Telemetric, Miniaturized Electrochemical Amperometric Analyzer.Sensors (Basel). 2017 Oct 23;17(10):2416. doi: 10.3390/s17102416. Sensors (Basel). 2017. PMID: 29065534 Free PMC article.
-
Recent Advances in the Fabrication and Functionalization of Flexible Optical Biosensors: Toward Smart Life-Sciences Applications.Biosensors (Basel). 2021 Apr 4;11(4):107. doi: 10.3390/bios11040107. Biosensors (Basel). 2021. PMID: 33916580 Free PMC article. Review.
-
Towards Portable Nanophotonic Sensors.Sensors (Basel). 2019 Apr 10;19(7):1715. doi: 10.3390/s19071715. Sensors (Basel). 2019. PMID: 30974832 Free PMC article. Review.
-
Detection of COVID-19 Virus on Surfaces Using Photonics: Challenges and Perspectives.Diagnostics (Basel). 2021 Jun 19;11(6):1119. doi: 10.3390/diagnostics11061119. Diagnostics (Basel). 2021. PMID: 34205401 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
